First Health Canada approved treatment for rare and aggressive type of skin cancer MISSISSAUGA, ON, 26-Feb-2018 — /EuropaWire/ — Merck, which operates as EMD Serono in the US and Canada, and Pfizer Canada Inc. announced that Health Canada has approved BAVENCIO™ … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged BAVENCIO™, cancer #skin cancer, Dr. John Walker, EMD Serono, health, Health Canada, Kathy Barnard, Merck, Merkelcell carcinoma, Pfizer Canada, skin, tumour
PARIS, 26-Feb-2018 — /EuropaWire/ — Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to Sanofi’s proposed acquisition of Bioverativ Inc. (“Bioverativ”, NASDAQ: BIVV) has expired. On February 7, … Read the full press release
Posted in Business, France, Pharma & Biotech
Tagged acquisition, ANTITRUST, Bioverativ, Hart-Scott-Rodino Antitrust Improvements Act, Healthcare, HSRAct, Sanofi
Imfinzi is the only immunotherapy approved for patients with unresectable Stage III non-small cell lung cancer Imfinzi showed an 11.2 month improvement in median progression-free survival (16.8 months compared to 5.6 months on placebo) CAMBRIDGE, 22-Feb-2018 — /EuropaWire/ — AstraZeneca and … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, Cancer, chemotherapy, Dave Fredrickson, Imfinzi, lung, lung cancer, lungcancer, MedImmune, radiation therapy, Scott J. Antonia MD Ph.D.
STUTTGART, 15-Feb-2018 — /EuropaWire/ — McKesson Europe has published its first Europe-wide Corporate Responsibility Report in accordance with the international Global Reporting Initiative (GRI) guidelines: The company provides insights into its sustainable handling of economic and ecological resources and informs readers … Read the full press release
Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA, 14-Feb-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies & Treatments for … Read the full press release
LUND, 13-Feb-2018 — /EuropaWire/ — Alfa Laval is expanding its successful range of UltraPure pharmaceutical pumps with an even larger selection. Whether a pharmaceutical or biotech process requires a centrifugal or PD (positive displacement) pump, the complete range of Alfa Laval … Read the full press release
Posted in Pharma & Biotech, Sweden, Technology
Tagged Alfa Laval, Biotech, John Walker, PD pump, pharma, pumps, UltraPure pharmaceutical pumps range
NUREMBERG, 07-Feb-2018 — /EuropaWire/ — Siemens AG and Perceptive Engineering Ltd announce a partnership which offers Perceptive’s PharmaMV and Siemens Simatic Sipat software products closely integrated to provide a versatile solution for advanced control and optimization applications in both continuous and … Read the full press release
Posted in Germany, Pharma & Biotech, Technology
Tagged Perceptive Engineering, pharmaceutical industry, Siemens, Simatic, software solution
GLASGOW, 05-Feb-2018 — /EuropaWire/ — A new joint venture company which brings together the University of Glasgow and Portage Pharmaceuticals is aiming to develop more effectively-targeted drugs to treat chronic conditions including cancer. Portage Pharmaceuticals, a subsidiary of the British Virgin … Read the full press release
SOUTHAMPTON, 02-Feb-2018 — /EuropaWire/ — The University of Southampton is delighted to announce it has reached its £25m target to fund the UK’s first dedicated centre for cancer immunology research. For decades, Southampton scientists have made a number of advances … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged cancer immunology research, Centre for Cancer Immunology, immunology, Patricia Marriott, Professor Sir Christopher Snowden, Professor Tim Elliott, The University of Southampton, University Hospital Southampton
Expands Sanofi’s presence in specialty care and strengthens leadership in rare diseases Adds leader in the growing hemophilia market and provides platform for expansion in other rare blood disorders Drives meaningful shareholder value with ROIC expected to exceed cost of … Read the full press release
The 2018 IUPAC-Richter Prize in Medicinal Chemistry has been awarded to Peter D.J. Grootenhuis. BUDAPEST, 30-Jan-2018 — /EuropaWire/ — Peter D.J. Grootenhuis received this award in recognition of his outstanding creative contributions to the invention, discovery, and development of the medicine … Read the full press release
Posted in Awards, Healthcare, Hungary, Pharma & Biotech
Tagged 2018 IUPAC-Richter Prize, Award, chemistry, Cystic Fibrosis, Medicinal Chemistry, medicine, Peter D.J. Grootenhuis
Toepfer joins from Metro Group, where he served as Head of the IT service company Metro Systems DARMSTADT, 26-Jan-2018 — /EuropaWire/ — Merck, a leading science and technology company, today announced that Dirk Toepfer will join the Group as the new … Read the full press release
Posted in Business, Chemicals, Germany, Management, Pharma & Biotech, Technology
Tagged chemical, Dirk Toepfer, Merck, Pharmaceutical, Udit Batra
LONDON, 22-Jan-2018 — /EuropaWire/ — Science Minister Sam Gyimah announces £70 million to create new manufacturing centres to help speed up the development of new medicines. Funding through Industrial Strategy Challenge Fund (ISCF) will support projects including new manufacturing centres to speed … Read the full press release
Posted in Financial, Government, Healthcare, Pharma & Biotech, United Kingdom
Tagged Brain, funding, Industrial Strategy Challenge Fund, Innovate UK, medicines, rehabilitation, RESEARCH, Sam Gyimah, Sir Mark Walport, stroke, treatments, VR
Lynparza is the first PARP inhibitor approved in Japan Lynparza tablets approved as maintenance treatment for women with platinum-sensitive relapsed ovarian cancer regardless of BRCA mutation status CAMBRIDGE, 22-Jan-2018 — /EuropaWire/ — AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, Dave Fredrickson, inhibitor, Japan, Lynparza, Lynparza (olaparib), ovarian cancer, PARP, Roy Baynes
Scientific European® (a popular science magazine) launched Tadworth, Surrey, United Kingdom, 20-Jan-2018 — /EuropaWire/ — UK Education Consultancy Services Ltd announced that the premiere issue of Scientific European® (a popular science magazine) is released today on 19 January 2018. Abbreviated … Read the full press release
Posted in Environment, Healthcare, Media, News, Pharma & Biotech, Science, Society, United Kingdom
Tagged Dr Rajeev Soni, eISSN 2514-9542, Jasmita Gill, magazine, online magazine, pISSN 2515-9534, popular science, popular science magazine, print magazine, science magazine, scientific advances, Scientific European, SCIEU®, UK Education Consultancy Services Ltd, Umesh Prasad
New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke DUBLIN, 17-Jan-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged artery, blood clot, Dr. Daniel Sahlein, Medtronic, Neurovascular, Riptide(TM) Aspiration System, Stacey Pugh, stroke, thrombus, U.S. FDA
DUBLIN, 16-Jan-2018 — /EuropaWire/ — At Shire, we’ve been committed to the hemophilia community and the lives of every patient afflicted with this disease for more than 70 years. We are very proud of this legacy and take our role as … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged Chugai, Genentech, Hemlibra, hemophilia, Howard Mayer M.D., IP, patent, rare diseases, Roche, Shire
Marketing Authorization will enable patient access to ADYNOVI throughout Europe ZUG, 16-Jan-2018 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, announced today that the European Commission (EC) has granted Marketing Authorization for ADYNOVI … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged ADYNOVI, bleeding, Dr. Peter Foertig MD, hemophilia A, rare diseases, Shire, treatment options
Anti-stress ingredient Hyalurosmooth® is a mindful way to cope with the effect of stress by regulating cortisol impact on skin New anti-aging active RNAge™ harnesses BASF’s findings in epigenetics and reshapes facial harmony Anti-aging active DN-Age™ slows down hair graying, counteracts hair loss … Read the full press release
Posted in Apparel, Fashion & Beauty, Chemicals, France, Germany, Marketing, Pharma & Biotech
Tagged Anti-Aging, Anti-Stress, BASF, Cosmetagora, DN-Age™, epigenetics, hair, Hyalurosmooth®, RNAge, skin, skin and hair care products, stress
Experts demonstrated both ex vivo production of physiological sebum in 3D human sebaceous gland model and its regulation by means of active ingredients Ludwigshafen, Germany, 10-Jan-2018 — /EuropaWire/ — Sebaceous glands help the skin stay moist and protect it against external … Read the full press release
Posted in Apparel, Fashion & Beauty, Chemicals, Germany, Pharma & Biotech, Science, Technology
Tagged 3D, 3D tissue models, BASF, BASF Care Creations, Cosmetic, CTIBiotech, Dr. Nico Forraz, Dr. Sabine Pain, NYSCC, NYSCC Cosmetic Congress, Professor Colin McGuckin, Sebaceous Glands, skincare, the Cell Therapy Research Institute, tissue
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?